Abiopharma

News list

Director Henricks Gwenne A. 🟢 acquired 560 shares of Polaris Inc. (PII) at $54.70 Transaction Date: Apr 01, 2026 | Filing ID: 023192

Full text

News bot April 2, 2026, 8:20 p.m.
🔍 Henricks Gwenne A. (Director)

Company: Polaris Inc. (PII)

Report Date: 2026-04-01
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 560
Detailed Transactions and Holdings:
- Acquired 560 shares of Common Stock at $54.7 per share (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 37,280.70 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The reported transaction involved the crediting of 559.87 Common Stock Equivalents (CSEs), each of which may be settled in one share of common stock, to the reporting person's account under the Company's Deferred Compensation Plan for Directors (DC Plan) in connection with the reporting person's election to defer receipt of the reporting person's quarterly cash retainer payment. The total reported in column 5 includes the 559.87 newly acquired CSEs, and 458.51 CSEs and deferred stock units acquired pursuant to the dividend reinvestment feature of the DC Plan.